{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:17:41Z","timestamp":1793449061589,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.xphs.2022.11.011","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T15:03:47Z","timestamp":1668351827000},"page":"1220-1224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Ranitidine: A Proposed Mechanistic Rationale for NDMA Formation and a Potential Control Strategy"],"prefix":"10.1016","volume":"112","author":[{"given":"Paul","family":"Harmon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2022.11.011_bib0001","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/cts.12995","article-title":"Is this the end for ranitidine? NDMA presence continues to confound","volume":"14","author":"Wagner","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.xphs.2022.11.011_bib0002","unstructured":"Najafi RR. Re: Emery Pharma citizen petition. Emery Pharma. 2020.https:\/\/emerypharma.com\/wp-content\/uploads\/2020\/01\/EP-Ranitidine-FDA-Citizen-Petition-v21-January-2-2020.pdf"},{"key":"10.1016\/j.xphs.2022.11.011_bib0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.38212\/2224-6614.1133","article-title":"N-nitrosodimethylamine (NDMA) contamination of ranitidine products: a review of recent findings","volume":"29","author":"Aldawsari","year":"2021","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.xphs.2022.11.011_bib0004","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acs.oprd.0c00462","article-title":"Ranitidine-investigations into the root cause for the presence of NNitrosoN,ndimethylamine in ranitidine hydrochloride drug substances and associated drug products","volume":"24","author":"King","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.11.011_bib0005","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1248\/cpb.c21-00289","article-title":"(NDMA) formation from ranitidine impurities: possible root causes of the presence of NDMA in ranitidine hydrochloride","volume":"69","author":"Yokoo","year":"2021","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.xphs.2022.11.011_bib0006","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1248\/cpb.c20-00431","article-title":"Temperature-dependent formation of N-nitrodimethyl amine during the storage of ranitidine reagent powders and tablets","volume":"68","author":"Abe","year":"2020","journal-title":"Chem Pharm Bull"},{"issue":"6","key":"10.1016\/j.xphs.2022.11.011_bib0007","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600820611","article-title":"Effects of temperature and humidity on the solid-state chemical stability of ranitidine hydrochloride","volume":"82","author":"Teraoka","year":"1993","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.11.011_bib0008","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1021\/acs.oprd.0c00224","article-title":"Potential for the formation of N-nitrosamines during the manufacture of active pharmaceutical ingredients: an assessment of the risk posed by trace nitrite in water","volume":"24","author":"Ashworth","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.11.011_bib0009","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/acs.oprd.0c00323","article-title":"Pathways for NNitroso compound formation: secondary amines and beyond","volume":"24","author":"Lopez-Rodr\u00edguez","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.11.011_bib0010","series-title":"Pharmaceutical Stress Testing \u2013 Predicting Drug Degradation","first-page":"168","article-title":"Oxidative susceptibility testing","author":"Harmon","year":"2011"},{"issue":"9","key":"10.1016\/j.xphs.2022.11.011_bib0011","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/jps.20668","article-title":"A novel peroxy radical based oxidative stressing system for predicting oxidative instability of active pharmaceutical ingredients","volume":"95","author":"Harmon","year":"2006","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2022.11.011_bib0012","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s11095-005-6947-z","article-title":"Mechanism of the solution oxidation of rofecoxib under alkaline conditions","volume":"22","author":"Harmon","year":"2005","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2022.11.011_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/ar50013a001","article-title":"Peroxy radicals","volume":"2","author":"Ingold","year":"1969","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.xphs.2022.11.011_bib0014","series-title":"Advances in Catalysis","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0360-0564(08)60316-8","article-title":"Metal catalyzed oxidations of organic compounds in the liquid phase: a mechanistic approach","author":"Sheldon","year":"1976"},{"issue":"22","key":"10.1016\/j.xphs.2022.11.011_bib0015","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1016\/S0040-4020(01)81002-4","article-title":"Chemistry of \u03b1-nitroepoxides: synthesis of useful intermediates via nucleophilic ring opening of \u03b1-nitroepoxides","volume":"47","author":"Vankar","year":"1991","journal-title":"Tetrahedron"},{"key":"10.1016\/j.xphs.2022.11.011_bib0016","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/op060011y","article-title":"Polymorphic generation through solvent selection: ranitidine hydrochloride","volume":"11","author":"Trifkovic","year":"2007","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.11.011_bib0017","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1126\/science.181.4106.1245","article-title":"N-nitrosation by nitrite ion in neutral and basic medium","volume":"181","author":"Keeper","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.xphs.2022.11.011_bib0018","doi-asserted-by":"crossref","unstructured":"Harmon PA. Trace aldehydes in solid dosage forms as catalysts for nitrosating secondary amines. J Pharm Sci. Published online. https:\/\/doi.org\/10.1016\/j.xphs.2022.10.033.","DOI":"10.1016\/j.xphs.2022.10.033"},{"issue":"A","key":"10.1016\/j.xphs.2022.11.011_bib0019","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jp8061674","article-title":"Theoretical investigation of N-nitrosodimethylamine formation from dimethylamine nitrosation catalyzed by carbonyl compounds","volume":"113","author":"Lv","year":"2009","journal-title":"J Phys Chem"},{"key":"10.1016\/j.xphs.2022.11.011_bib0020","unstructured":"Many different oxygen scavenging systems are available, see for example https:\/\/www.multisorb.com\/oxygen-absorbers\/"},{"key":"10.1016\/j.xphs.2022.11.011_bib0021","series-title":"Autooxidation in Food and Biological Systems","first-page":"387","article-title":"Antioxidants as blocking agents against nitrosamine formation","author":"Mergens","year":"1980"},{"key":"10.1016\/j.xphs.2022.11.011_bib0022","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.xphs.2021.08.010","article-title":"Inhibition of N-nitrosamine formation in drug products: a model study","volume":"110","author":"Nanda","year":"2021","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922005214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922005214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:39:53Z","timestamp":1758361193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922005214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0022354922005214"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.11.011","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranitidine: A Proposed Mechanistic Rationale for NDMA Formation and a Potential Control Strategy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}